A Multi-Organ Murine Metabolomics Atlas Reveals Molecular Dysregulations in Alzheimer’s Disease
Authors:
- Simone ZuffaSZSimone Zuffa
- Celeste AllabandCACeleste Allaband
- Vincent Charron-LamoureuxVCVincent Charron-Lamoureux
- Andres Mauricio Caraballo-RodriguezACAndres Mauricio Caraballo-Rodriguez
- Abubaker PatanAPAbubaker Patan
- John W. BostickJBJohn W. Bostick
- T. Jaymie ConnerlyTCT. Jaymie Connerly
- Matheus de Castro FonsecaMFMatheus de Castro Fonseca
Preprint
Abstract
SUMMARY: The etiology of Alzheimer’s Disease (AD) remains largely unclear but is likely driven by gene-environment interactions. Here, we present a multi-organ untargeted metabolomics dataset (2,271 samples) generated from five tissue types in two genetic AD mouse models under colonized or germ-free conditions, complemented by shotgun metagenomics sequencing data (666 samples). Systems-level analyses of 3xTg and 5xFAD mice reveal clusters of dysregulated molecular classes across tissues including carnitines, bile acids, B vitamins, and neurotransmitters. This signature, coupled with microbiome profiles, suggests increased oxidative stress via mitochondrial dysfunction. Molecular feature tracking via tissueMASST, a mass spectrometry search tool we developed to bridge animal model findings with human data, identifies microbially-modulated phenylacetyl-carnitine as positively associated with aging and cognitive impairment across human AD studies. With hundreds of yet-to-be-characterized metabolites, this public resource and its associated tools will aid future research in the pathophysiology of AD.Keywords
Funding Information
- Santé (335368)
This publication has 136 references indexed in Scilit:
- Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent MannerAdvanced Science, 2023
- Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's diseaseAlzheimer's & Dementia, 2023
- Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's diseaseAlzheimer's & Dementia, 2021
- Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 DiabetesAdvanced Science, 2021
- Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)Alzheimer's & Dementia, 2021
- The human symbiont Mucispirillum schaedleri: causality in health and diseaseMedical Microbiology and Immunology, 2021
- Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementiasCochrane Database of Systematic Reviews, 2015
- Partial least squares for discriminationJournal of Chemometrics, 2003
- Benzoate therapy and carnitine deficiency in non‐ketotic hyperglycinemiaAmerican Journal of Medical Genetics, 1995
- Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl‐coa dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1990